sStatement of Cash FlowsIndirect Method

The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows:

		Dec. 31, 20Y3		Dec. 31, 20Y2
Assets
Cash		$269,200		$248,970
Accounts receivable (net)		97,520		89,420
Inventories		275,290		264,760
Investments		0		102,570
Land		141,200		0
Equipment		303,740		234,070
Accumulated depreciationequipment		(71,110)		(63,120)
	Total assets	$1,015,840		$876,670
Liabilities and Stockholders' Equity
Accounts payable (merchandise creditors)		$183,870		$172,700
Accrued expenses payable (operating expenses)		18,290		22,790
Dividends payable		10,160		7,890
Common stock, $10 par		54,860		42,960
Paid-in capital: Excess of issue price over par-common stock		206,220		119,230
Retained earnings		542,440		511,100
	Total liabilities and stockholders equity	$1,015,840		$876,670

Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows:

The investments were sold for $120,010 cash.

Equipment and land were acquired for cash.

There were no disposals of equipment during the year.

The common stock was issued for cash.

There was a $72,540 credit to Retained Earnings for net income.

There was a $41,200 debit to Retained Earnings for cash dividends declared.

Required:

Prepare a statement of cash flows, using the indirect method of presenting cash flows from operating activities. Use the minus sign to indicate cash out flows, cash payments, decreases in cash, or any negative adjustments.

Livers Inc.

Statement of Cash Flows

For the Year Ended December 31, 20Y3

Cash flows from operating activities: Adjustments to reconcile net income to net cash flow from operating activities: Changes in current operating assets and liabilities: Net cash flow from operating activities Cash flows from investing activities: Net cash flow used for investing activities Cash flows from financing activities: Net cash flow from financing activities Cash at the beainnina of the vear